Page 218 - IJB-8-3
P. 218

Stakeholder Perspectives on the Current and Future of Additive Manufacturing in Healthcare
           finish  (3.6  ±  1.7)  or  mechanical  behavior  (4.7  ±  0.8)   increased confidence in their adoption [41-43] . Nevertheless,
           and biological compatibility (3.7 ± 2.0) are the highest   certification is still considered one of the main constraints
           and lowest priorities for academia and manufacturing,   of  modern AM [29,40,44] , which  may  explain  the  required
           respectively.  As expected,  biological  compatibility   features for success mentioned in this survey.
           overshadows all  other  requirements  from  a  medical
           perspective (5.0 ± 0.0), with repeatability ranked lowest   3.4. Advantages, limitations, and future
           (3.8 ± 1.6).                                        perspectives of AM
               From the point of view of academic,  design and   To expand our understanding  on the vision of AM as
           manufacturing  experts, simplicity, repeatability, part   seen by different specialists, specific details were asked
           quality,  and  flexibility  are  some  of  the  most  desirable   on the main advantages and disadvantages in healthcare
           features  (Figure  2A) and are heavily  needed  for a   (Figure  5A,  B  and  Tables S15,  S16). Based  on  the
           successful part (Figure  2C) while less sought for by   obtained data, it is clear that personalization, prototyping,
           medical  practitioners.  Decoupling  of customization   design control, and lead times are the main benefits for
           and cost is often regarded as a fundamental  driver to   academics  and  designers,  although  the  latter  indicated
           the growth of  AM in healthcare,  allowing to bypass   prototyping  and  personalization  (23.1%) as the  most
           traditional economies of scale coining the term “economy   valued  characteristics.  Manufacturers  follow this trend
           of one” . Personalization is highly desirable in complex   highly  rating  prototyping  and design control  (21.7%),
                 [38]
           clinical cases where the surgeon can control the design,   although  other advantages  were indicated  (i.e.,  batch
           although it poses a heavy burden on regulations. Since   size and manufacturing of assembled parts). Similarly,
           the advent of AM, it has become clear that each process   medical  experts  focus on personalization  followed  by
           can  be  significantly  influenced  by  numerous  input   batch size, design control, entry cost, and lead times.
           manufacturing parameters, which can result in products   The consequence of these valued properties of AM could
           that do not meet quality control (QC) requirements [29,39] .   reveal  that the technology, currently  sold as a highly
           Combining this with limited  standardization  and   versatile process capable of complex bespoke designs, is
           regulatory  advice  resulted in an initial  preference  of   in agreement with how most specialists currently view
           AM in non-critical parts that do not require regulatory   these techniques.
           approval and the use of in house specifications . Over   The main disadvantages of modern AM as perceived
                                                   [40]
           the last decade, new standards resulting from ASTM and   from the obtained data (Figure 5B) seem to come from
           ISO collaborations encompassing  AM has supported   the expertise needed to use the systems, the achievable

                        A                                      B













                        C
                                                               D















           Figure 5. Additive manufacturing (A) advantages and (B) disadvantages as seen by each profession and areas where these processes would
           be of interest to further apply (C) currently or (D) if their main disadvantages are overcome.

           210                         International Journal of Bioprinting (2022)–Volume 8, Issue 3
   213   214   215   216   217   218   219   220   221   222   223